Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UFD1P1 is a pseudogene, not a protein-coding gene. It is named 'UFD1 pseudogene 1' and, as indicated by its classification as a pseudogene, it does not encode a functional protein product and has no established biological activity, disease relevance, or therapeutic utility. While the closely related protein-coding gene *UFD1* ("Ubiquitin recognition factor in ER-associated degradation 1") is involved in the ER-associated degradation (ERAD) pathway, cell cycle regulation, and is implicated in certain diseases such as T-cell acute lymphoblastic leukemia and DiGeorge syndrome[1][2][3], UFD1P1 provides neither a protein product nor known physiological or pathological function. Thus, it is not considered a therapeutic target. **Note:** There may be confusion between *UFD1* (a functional protein-coding gene and valid research/therapeutic target) and *UFD1P1* (a non-functional pseudogene)[1]. UFD1P1 itself does not fulfill criteria for a drug target and should not be listed as such.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UFD1 pseudogene 1 (UFD1P1).